I'm not in ...some Third World place': bladder cancer patients face ongoing scarcity of life-saving drug

16 September 2019 - Canada's only supplier, Merck, is now projecting BCG shortage will last until December 2020. ...

Read more →

Canada OKs Celltrion's biosimilar

10 September 2019 - Celltrion said that Health Canada has given the go-ahead for Herzuma (trastuzumab), an anticancer antibody biosimilar, ...

Read more →

Health Canada updates its biosimilar fact sheet

4 September 2019 - Health Canada recently updated its fact sheet on biosimilars, including new or clarified information about key ...

Read more →

‘Nobody can afford this’: family left helpless after Health Canada approves official version of prescription eye drops

28 August 2019 - From the time she was diagnosed with an ultra-rare metabolic disorder as a toddler, Olivia Little ...

Read more →

Health Canada approves Tecentriq (atezolizumab), first new treatment in 20 years for aggressive form of lung cancer

13 August 2019 - Data show Tecentriq in combination with carboplatin and etoposide helped patients with extensive-stage small cell lung ...

Read more →

Shortages feared as U.S. looks to Canada for cheaper prescription drugs

31 July 2019 - Canada 'will ensure there are no adverse effects on the supply or cost of prescription drugs,' says ...

Read more →

Health Canada approves Vitrakvi (larotrectinib), the first tumour agnostic cancer treatment for advanced solid tumours harbouring an NTRK gene fusion

30 July 2019 - Bayer announced today that there is now a treatment in Canada for tyrosine receptor kinase fusion ...

Read more →

Platelet rich plasma treatment is not classified as a drug, Health Canada says

27 July 2019 - Agency clarifies its position on controversial treatment made popular by superstar athletes. ...

Read more →

Federal health minister announces new treatment options for children

25 July 2019 - Health Minister Ginette Petitpas Taylor made the announcement at Health Sciences North in Sudbury on Thursday. ...

Read more →

Alnylam launches Onpattro (patisiran) for the treatment of polyneuropathy in hATTR amyloidosis, the first-ever RNAi therapeutic approved in Canada

23 July 2019 - Onpattro is the only treatment that demonstrated improvement, relative to baseline, in both polyneuropathy and quality ...

Read more →

Knight Therapeutics announces Health Canada has approved Nerlynx for early-stage breast cancer

16 July 2019 - Knight Therapeutics announced today that Health Canada has approved Nerlynx (neratinib) for the extended adjuvant treatment of ...

Read more →

National regulator denied offer to give Canadian physicians training on abortion pill

16 July 2019 - The group representing Canada’s family doctors turned down an offer from a national abortion group to ...

Read more →

Esperoct is now approved in Canada for the treatment of haemophilia A in both children and adults

12 July 2019 - New treatment can help Canadians living with haemophilia A better manage their bleeding episodes ...

Read more →

Health Canada has authorised Vyvanse (lisdexamphetamine dimesylate), the first and only, chewable tablet for the treatment of attention deficit/hyperactivity disorder

10 July 2019 - Vyvanse offers an additional option for patients who prefer the convenience of a chewable tablet, or who ...

Read more →

Health Canada approves Pomalyst-based triplet combination for patients with multiple myeloma

10 July 2019 - Pomalyst in combination with bortezomib and dexamethasone, provides a new medication option for patients living with multiple ...

Read more →